Alida Biosciences

About

Alida Biosciences is a biotechnology startup based in San Diego, California, founded in 2020. The company focuses on epitranscriptomics, which involves studying chemical modifications on RNA molecules that influence various biological processes. Alida develops innovative tools for high-throughput analysis of these modifications, aiming to enhance research in RNA biology. The company's flagship platform, EpiPlex™, utilizes proximity barcoding and engineered protein binders to detect and quantify multiple RNA modification types in a streamlined workflow compatible with standard RNA-Seq pipelines. Key offerings include EpiPlex™ RNA Mod Encoding Kits for accurate multi-target detection and EpiScout™ Analysis Software, which leverages machine learning to convert raw sequencing data into actionable insights. Alida's tools support researchers in mapping RNA modifications related to health and disease, with applications in drug discovery, disease diagnosis, and personalized medicine. The company aims to advance RNA biology research, including RNA therapies and mRNA vaccines, by uncovering RNA biomarkers and illuminating complex genomic elements.